fludarabine phosphate
accord healthcare limited - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents
fludarabine juno fludarabine phosphate 50 mg powder for injection vial
juno pharmaceuticals pty ltd - fludarabine phosphate, quantity: 50 mg - injection, powder for - excipient ingredients: mannitol; sodium hydroxide - treatment of b-cell chronic lymphocytic leukaemia
fludara 50 mg powder for solution for injection or infusion
genzyme europe b.v. - fludarabine phosphate - powder for solution for injection/infusion - 50 milligram(s) - purine analogues; fludarabine
fludarabine phosphate 25mg/ml concentrate for solution for injection/infusion
actavis group ptc ehf - fludarabine phosphate - concentrate for solution for injection/infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine
fludarabine phosphate 25mg/ml concentrate for solution for injection or infusion
accord healthcare ireland ltd. - fludarabine phosphate - concentrate for solution for injection/infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine
fludarabine phosphate injection, powder, lyophilized, for solution
hospira, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 50 mg in 2 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate, usp is contraindicated in those patients who are hypersensitive to this drug or its components.
fludarabine phosphate- fludarabine phosphate injection, powder, lyophilized, for solution
sagent pharmaceuticals - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 25 mg in 1 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate for injection, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate for injection is contraindicated in those patients who are hypersensitive to this drug or its components.
fludarabine phosphate injection, powder, lyophilized, for solution
actavis pharma, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 50 mg in 2 ml - fludarabine phosphate for injection is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate for injection in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate for injection is contraindicated in those patients who are hypersensitive to this drug or its components.
fludarabine phosphate injection, powder, lyophilized, for solution
hikma pharmaceuticals usa inc. (dba leucadia pharmaceuticals) - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 25 mg in 1 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate for injection, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate for injection is contraindicated in those patients who are hypersensitive to this drug or its components.
fluarix tetra suspension for injection
glaxosmithkline pte ltd - influenza virus (sh) a/thailand/8/2022 (h3n2) - like strain; influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain; influenza virus (sh) b/austria/1359417/2021 - like strain; influenza virus (sh) b/phuket/3073/2013-like strain - injection, suspension - influenza virus (sh) a/thailand/8/2022 (h3n2) - like strain 15mcg ha/0.5ml; influenza virus (sh) a/victoria/4897/2022 (h1n1)pdm09-like strain 15mcg ha/0.5ml; influenza virus (sh) b/austria/1359417/2021 - like strain 15mcg ha/0.5ml; influenza virus (sh) b/phuket/3073/2013-like strain 15mcg ha/0.5ml